Market Overview

Barrington Research Maintains DENTSPLY $45 PT, Outperform

Barrington Research maintained its DENTSPLY (NASDAQ: XRAY) $45 price target and Outperform rating in a research report published today.

In the report, Barrington Research states, "Management initiated fiscal 2012 guidance to a range of $2.22-2.30 per diluted share on adjusted basis. Currency exchange rates are expected to have a negative impact in 2012 on both top and bottom lines. The company cited innovation, a key driver of its results in 2011 and noted that there were several exciting new products in the pipeline."

Shares of DENTSPLY closed today at $38.74, down 0.79% from Friday's market close.

Posted-In: Barrington ResearchAnalyst Color Price Target Analyst Ratings

 

Related Articles (XRAY)

Around the Web, We're Loving...

Get Benzinga's Newsletters